Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries
NCT ID: NCT05429489
Last Updated: 2024-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
126 participants
INTERVENTIONAL
2022-06-27
2024-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Block Versus PECS Block Type II for Breast Surgeries
NCT04284124
Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery
NCT02946294
Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery
NCT04218149
Compare Analgesia Between MTP Block And ESPB in MRM
NCT06888258
Comparison of Erector Spinae Plane Block With Serratus Anterior Plane Block for Breast Surgery
NCT03579524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilevel erector spinae plane block
Bilevel erector spinae block at 3rd and 5th thoracic vertebral levels
Bilevel erector spinae plane block
Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels
Single level erector spinae plane block
single level erector spinae plane block at 5th thoracic vertebral levels
Single level erector spinae plane block
Single level erector spinae plane block at 5th thoracic vertebrae
Intravenous morphine
Intravenous morphine 0.1 mg/ kg
Intravenous morphine
Intravenous morphine 0.1 mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bilevel erector spinae plane block
Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels
Single level erector spinae plane block
Single level erector spinae plane block at 5th thoracic vertebrae
Intravenous morphine
Intravenous morphine 0.1 mg/kg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with breast cancer
Exclusion Criteria
* coagulation defects
* bone metastases
* abnormal kidney and/or liver function tests
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Assistant professor of Anesthesia and Pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walaa Y Elsabeeny
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2205-5015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.